ArticleBritish journal of cancer2018

AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status.

Rui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.